1. Home
  2. DNLI vs EVH Comparison

DNLI vs EVH Comparison

Compare DNLI & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • EVH
  • Stock Information
  • Founded
  • DNLI 2013
  • EVH 2011
  • Country
  • DNLI United States
  • EVH United States
  • Employees
  • DNLI N/A
  • EVH N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • EVH Other Consumer Services
  • Sector
  • DNLI Health Care
  • EVH Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • EVH Nasdaq
  • Market Cap
  • DNLI 3.3B
  • EVH 3.8B
  • IPO Year
  • DNLI 2017
  • EVH 2015
  • Fundamental
  • Price
  • DNLI $21.43
  • EVH $10.82
  • Analyst Decision
  • DNLI Strong Buy
  • EVH Strong Buy
  • Analyst Count
  • DNLI 11
  • EVH 10
  • Target Price
  • DNLI $40.40
  • EVH $25.90
  • AVG Volume (30 Days)
  • DNLI 815.8K
  • EVH 2.6M
  • Earning Date
  • DNLI 11-06-2024
  • EVH 11-07-2024
  • Dividend Yield
  • DNLI N/A
  • EVH N/A
  • EPS Growth
  • DNLI N/A
  • EVH N/A
  • EPS
  • DNLI N/A
  • EVH N/A
  • Revenue
  • DNLI N/A
  • EVH $2,464,254,000.00
  • Revenue This Year
  • DNLI N/A
  • EVH $31.68
  • Revenue Next Year
  • DNLI $420.35
  • EVH $14.35
  • P/E Ratio
  • DNLI N/A
  • EVH N/A
  • Revenue Growth
  • DNLI 204.74
  • EVH 37.65
  • 52 Week Low
  • DNLI $14.56
  • EVH $10.53
  • 52 Week High
  • DNLI $33.33
  • EVH $35.00
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 31.13
  • EVH 31.55
  • Support Level
  • DNLI $22.61
  • EVH $10.70
  • Resistance Level
  • DNLI $24.15
  • EVH $12.01
  • Average True Range (ATR)
  • DNLI 1.09
  • EVH 0.54
  • MACD
  • DNLI -0.15
  • EVH 0.37
  • Stochastic Oscillator
  • DNLI 7.59
  • EVH 12.55

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Share on Social Networks: